Low risk patients: TAVI or surgical replacement?

Original Title: Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Low-Risk Patients.

Reference: Stefano Rosato et al. Circ Cardiovasc Interv. 2016 May;9(5):e003326.
The proved efficacy of transcatheter aortic valve implantation (TAVI) in high risk patients is leading the expansion of its indication for lower risk patients. All the same, compared to the information available on surgical valve replacement (SAVR), there is little evidence to support this change.

This analyzis describes TAVI vs. SAVR oucomes in low risk patients with severe aortic stenosis. It compared outcomes after TAVI and SAVR of low risk patients (European System for Cardiac Operative Risk Evaluation II [EuroSCORE II] <4%) incluided in the Observational Study of Effectiveness of SAVR–TAVI Procedures for Severe Aortic Stenosis Treatment (OBSERVANT).

Primary end point was survival at 3 years and secondary end point were early major cardiac and cerebrovascular events (MACCE) and at 3 years. 355 pairs of similar baseline characteristics were matched using propensity score.

 

Results
Survival at 30 days was 97.1% after SAVR and 97.4% after TAVI (p=0.82).
Cardiac tamponade, need of definite pacemaker, vascular complications and moderate to severe aortic regurgitation were significantly more frequent in patients receiving TAVI.
Even though stroke rate was the same in both groups, cardiogenic shock, major bleeding and acute kidney failure rates were higher with SAVR.
At 3 years, survival with SAVR was 83.4% vs. 72% with TAVI (p=0.0015). Freedom of MACCE was 80.9% for SAVR and 67.3% for TAVI (p<0.001).

 

Conclusion
In patients with symptomatic severe aortic stenosis and lower surgical risk, surgery showed significantly higher survival rates at 3 years compared to TAVI, according to this observational study.

More studies on new generation valve are necessary before expanding TAVI to lower risk patients.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...